Keywords
Last Name
Institution

DAVID DANIEL SCHWARTZ

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Psychology
AddressONE BAYLOR PLAZA
HOUSTON TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wasserman R, Anderson BJ, Schwartz DD. Illness-Specific Risk-Taking in Adolescence: A Missing Piece of the Nonadherence Puzzle for Youth With Type 1 Diabetes? Diabetes Spectr. 2017 Feb; 30(1):3-10. PMID: 28270709.
      View in: PubMed
    2. Schwartz DD, Stewart SD, Aikens JE, Bussell JK, Osborn CY, Safford MM. Seeing the Person, Not the Illness: Promoting Diabetes Medication Adherence Through Patient-Centered Collaboration. Clin Diabetes. 2017 Jan; 35(1):35-42. PMID: 28144044.
      View in: PubMed
    3. May L, Schwartz DD, Frugé E, Laufman L, Holm S, Kamdar K, Harris L, Brackett J, Unal S, Tanyildiz G, Bryant R, Suzawa H, Dreyer Z, Okcu MF. Predictors of Suboptimal Follow-up in Pediatric Cancer Survivors. J Pediatr Hematol Oncol. 2016 Dec 14. PMID: 27984354.
      View in: PubMed
    4. Wasserman RM, Anderson BJ, Schwartz DD. Screening of Neurocognitive and Executive Functioning in Children, Adolescents, and Young Adults With Type 1 Diabetes. Diabetes Spectr. 2016 Nov; 29(4):202-210. PMID: 27899871.
      View in: PubMed
    5. Klouda L, Franklin WJ, Saraf A, Parekh DR, Schwartz DD. Neurocognitive and executive functioning in adult survivors of congenital heart disease. Congenit Heart Dis. 2017 Jan; 12(1):91-98. PMID: 27650247.
      View in: PubMed
    6. Wasserman R, Anderson BJ, Schwartz DD. Illness-specific risk-taking in adolescence: A missing piece of the nonadherence puzzle for youth with type 1 diabetes?. Diabetes Spectr. 2016.
    7. Wasserman RM, Hilliard ME, Schwartz DD, Anderson BJ. Practical strategies to enhance executive functioning and strengthen diabetes management across the lifespan. Curr Diab Rep. 2015 Aug; 15(8):622. PMID: 26084581.
      View in: PubMed
    8. Antonini TN, Van Horn Kerne V, Axelrad ME, Karaviti LP, Schwartz DD. Neurocognitive profile of a young adolescent with DK phocomelia/von Voss phocomelia/von Voss Cherstvoy syndrome. Am J Med Genet A. 2015 Jul; 167(7):1632-6. PMID: 25899150.
      View in: PubMed
    9. Naranjo D, Schwartz DD, Delamater AM. Diabetes in ethnically diverse youth: disparate burden and intervention approaches. Curr Diabetes Rev. 2015; 11(4):251-60. PMID: 25901501.
      View in: PubMed
    10. Schwartz DD, Axelrad ME. SpringerBriefs in Child Health. Healthcare partnerships for pediatric adherence: promoting collaborative management for pediatric chronic illness care. 2015.
    11. Schwartz DD, Wasserman R, Powell PW, Axelrad ME. Neurocognitive outcomes in pediatric diabetes: a developmental perspective. Curr Diab Rep. 2014 Oct; 14(10):533. PMID: 25142718; PMCID: PMC4864497.
    12. Schwartz DD, Axelrad ME, Anderson BJ. Neurocognitive functioning in children and adolescents at the time of type 1 diabetes diagnosis: associations with glycemic control 1 year after diagnosis. Diabetes Care. 2014 Sep; 37(9):2475-82. PMID: 24969580.
      View in: PubMed
    13. Schwartz DD, Axelrad ME, Anderson BJ. A psychosocial risk index for poor glycemic control in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2014 May; 15(3):190-7. PMID: 24118977.
      View in: PubMed
    14. Schwartz DD, Katzenstein JM, Hopkins E, Stabley DL, Sol-Church K, Gripp KW, Axelrad ME. Verbal memory functioning in adolescents and young adults with Costello syndrome: evidence for relative preservation in recognition memory. Am J Med Genet A. 2013 Sep; 161A(9):2258-65. PMID: 23918324; PMCID: PMC3745536.
    15. Treble A, Chapman SG, Schwartz DD, Axelrad ME. Brief behavioral intervention for disruptive behavior in a child following frontal and temporal resection for medically intractable epilepsy: A case report. Clinical Practice in Pediatric Psychology. 2013; 1:355-360.
    16. Schwartz DD, Axelrad ME, Anderson BJ. Psychosocial risk screening of children newly diagnosed with type 1 diabetes: a training toolkit for healthcare professionals. 2013.
    17. Hansen JA, Weissbrod C, Schwartz DD, Taylor WP. Paternal involvement in pediatric Type 1 diabetes: fathers' and mothers' psychological functioning and disease management. Fam Syst Health. 2012 Mar; 30(1):47-59. PMID: 22429078.
      View in: PubMed
    18. Cline GD, Schwartz DD, Axelrad ME, Anderson B. A pilot study of acute stress symptoms in parents and youth following diagnosis of type I diabetes. J Clin Psychol Med Settings. 2011 Dec; 18(4):416-22. PMID: 21938395.
      View in: PubMed
    19. Axelrad ME, Schwartz DD, Katzenstein JM, Hopkins E, Gripp KW. Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review. Am J Med Genet C Semin Med Genet. 2011 May 15; 157C(2):115-22. PMID: 21495179.
      View in: PubMed
    20. Schwartz DD, Cline VD, Axelrad ME, Anderson BJ. Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes. Diabetes Care. 2011 Feb; 34(2):326-31. PMID: 21216856; PMCID: PMC3024342.
    21. Schwartz DD, Axelrad ME, Cline VD, Anderson BJ. A model psychosocial screening program for children and youth with newly diagnosed type 1 diabetes: Implications for psychologists across contexts of care. Professional Psychology: Research and Practice. 2011; (42):324-330.
    22. Schwartz DD, Cline VD, Hansen JA, Axelrad ME, Anderson BJ. Early risk factors for nonadherence in pediatric type 1 diabetes: a review of the recent literature. Curr Diabetes Rev. 2010 May; 6(3):167-83. PMID: 20380630.
      View in: PubMed
    23. Axelrad ME, Schwartz DD, Fehlis JE, Hopkins E, Stabley DL, Sol-Church K, Gripp KW. Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome. Am J Med Genet A. 2009 Dec; 149A(12):2666-72. PMID: 19919001; PMCID: PMC2787985.
    24. Taylor KH, Smith AN, Higginbotham M, Schwartz DD, Carpenter DM, Whitley EM. Expression of vascular endothelial growth factor in canine oral malignant melanoma. Vet Comp Oncol. 2007 Dec; 5(4):208-18. PMID: 19754779.
      View in: PubMed
    25. Flournoy WS, Wohl JS, Albrecht-Schmitt TJ, Schwartz DD. Pharmacologic identification of putative D1 dopamine receptors in feline kidneys. J Vet Pharmacol Ther. 2003 Aug; 26(4):283-90. PMID: 12887611.
      View in: PubMed
    26. Sartin JL, Elsasser TH, Kahl S, Baker J, Daniel JA, Schwartz DD, Steele B, Whitlock BK. Estradiol plus progesterone treatment modulates select elements of the proinflammatory cytokine cascade in steers: attenuated nitric oxide and thromboxane B2 production in endotoxemia. J Anim Sci. 2003 Jun; 81(6):1546-51. PMID: 12817503.
      View in: PubMed
    27. Sartin JL, Shores MA, Schwartz DD, Kemppainen RJ, Baker J. Reduced growth of calves and its reversal by use of anabolic agents. Domest Anim Endocrinol. 2000 Aug; 19(2):85-92. PMID: 11025188.
      View in: PubMed
    28. Schwartz DD, Jones WG, Hedden KP, Clark TP. Molecular and pharmacological characterization of the canine brainstem alpha-2A adrenergic receptor. J Vet Pharmacol Ther. 1999 Dec; 22(6):380-6. PMID: 10651467.
      View in: PubMed
    29. Schwartz DD, Clark TP. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep. J Vet Pharmacol Ther. 1998 Oct; 21(5):342-7. PMID: 9811433.
      View in: PubMed
    30. Henegar JR, Schwartz DD, Janicki JS. ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. Am J Physiol. 1998 Aug; 275(2 Pt 2):H534-41. PMID: 9683442.
      View in: PubMed
    31. Schwartz DD, Clark TP. Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes. J Vet Pharmacol Ther. 1998 Apr; 21(2):107-11. PMID: 9597647.
      View in: PubMed
    32. Schwartz DD, Naff BP. Activation of protein kinase C by angiotensin II decreases beta 1-adrenergic receptor responsiveness in the rat heart. J Cardiovasc Pharmacol. 1997 Feb; 29(2):257-64. PMID: 9057076.
      View in: PubMed
    33. Oellerich WF, Schwartz DD, Malik KU. Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanism. Neuroscience. 1994 May; 60(2):495-502. PMID: 8072693.
      View in: PubMed
    34. Schwartz DD, Malik KU. Cyclic AMP modulates but does not mediate the inhibition of [3H]norepinephrine release by activation of alpha-2 adrenergic receptors in cultured rat ganglion cells. Neuroscience. 1993 Jan; 52(1):107-13. PMID: 8094543.
      View in: PubMed
    SCHWARTZ's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _